Fluid Biomarkers in Alzheimer Disease

Blennow, K., Zetterberg, H., Fagan, A. M.·2012·Cold Spring Harbor Perspectives in Medicine

DOI 10.1101/cshperspect.a006221

Cited by (208)

Items 101–200 of 208

(Neuro) Peptides, Physical Activity, and Cognition
Juho Autio, V. Stenbäck, D. Gagnon, J. Leppäluoto, K. Herzig · 2020 · Journal of Clinical Medicine
Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease (Review)
Mubashir Hassan, Qamar Abbas, Sung‐Yum Seo, Saba Shahzadi, Hany Alashwal, Nazar Zaki, Zeeshan Iqbal, Ahmed A. Moustafa · 2018 · Molecular Medicine Reports
Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism
Radu Constantinescu, Lars Rosengren, Barbro Eriksson, Kaj Blennow, Markus Axelsson · 2019 · Acta Neurologica Scandinavica
Endostatin Level in Cerebrospinal Fluid of Patients with Alzheimer's Disease
Romain Salza, Jean‐Baptiste Oudart, Laurent Ramont, François‐Xavier Maquart, Serge Bakchine, H. Thoannes, Sylvie Ricard‐Blum · 2015 · Journal of Alzheimer s Disease
Cerebrospinal Fluid Biomarkers of Pediatric Hydrocephalus
David D. Limbrick, Leandro Castañeyra-Ruiz, Rowland H. Han, Daniel Berger, James Pat McAllister, Diego M. Morales · 2017 · Pediatric Neurosurgery
Aftins Increase Amyloid-β42, Lower Amyloid-β38, and Do Not Alter Amyloid-β40 Extracellular Production in vitro: Toward a Chemical Model of Alzheimer's Disease?
Arnaud Hochard, Nassima Oumata, Karima Bettayeb, Olfa Gloulou, Xavier Fant, Émilie Durieu, Nelly Buron, Mathieu Porceddu, Annie Borgne‐Sanchez, Hervé Galons et al. · 2013 · Journal of Alzheimer s Disease
Cerebrospinal fluid biomarkers for pathological processes in Alzheimer's disease
Christoffer Rosén, Henrik Zetterberg · 2013 · Current Opinion in Psychiatry
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
Simon Sjödin, Annika Öhrfelt, Gunnar Brinkmalm, Henrik Zetterberg, Kaj Blennow, Ann Brinkmalm · 2016 · Clinical Proteomics
Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies
Maxime Hallé, Pascale Tribout-Jover, Anne-Marie Lanteigne, Jonathan Boulais, Julien R. St-Jean, Rachel Jodoin, Marie‐Pier Girouard, Florin Constantin, Annik Migneault, Frédéric Renaud et al. · 2015 · Journal of Immunological Methods
Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians
Pedro Rosa‐Neto, Ging‐Yuek Robin Hsiung, Mario Masellis, on behalf of the CCDTD4 participants · 2013 · Alzheimer s Research & Therapy
Age, sex and APOE-ε4 modify the balance between soluble and fibrillar β-amyloid in non-demented individuals: topographical patterns across two independent cohorts
Raffaele Cacciaglia, Gemma Salvadó, José Luís Molinuevo, Mahnaz Shekari, Carles Falcón, Grégory Operto, Marc Suárez‐Calvet, Marta Milà‐Alomà, Arianna Sala, Elena Rodriguez‐Vieitez et al. · 2022 · Molecular Psychiatry
Cerebrospinal Fluid Concentrations of Extracellular Matrix Proteins in Alzheimer’s Disease
Karolina Minta, Erik Portelius, Shorena Janelidze, Oskar Hansson, Henrik Zetterberg, Kaj Blennow, Ulf Andréasson · 2019 · Journal of Alzheimer s Disease
SIMOA Diagnostics on Alzheimer’s Disease and Frontotemporal Dementia
Athanasia Chatziefstathiou, Sezgi Canaslan, Ειrini Kanata, Kostas Vekrellis, Vasilios C. Constantinides, George P. Paraskevas, Elisabeth N. Kapaki, Matthias Schmitz, Inga Zerr, Konstantinos Xanthopoulos et al. · 2024 · Biomedicines
Default mode network connectivity is linked to cognitive functioning and CSF Aβ1–42 levels in Alzheimer’s disease
Özlem Önerci Çelebi, Andaç Uzdoğan, Kader Karlı Oğuz, Arzu Ceylan Has, Anıl Dolgun, Gül Yalçın Çakmaklı, Filiz Akbıyık, Bülent Elibol, Esen Saka · 2015 · Archives of Gerontology and Geriatrics
Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit
Sterling C. Johnson, Marc Suárez‐Calvet, Ivonne Suridjan, Carolina Minguillón, Juan Domingo Gispert, Erin McMullen Jonaitis, Agata Michna, Margherita Carboni, Tobias Bittner, Christina Rabe et al. · 2023 · Alzheimer s Research & Therapy
Biomarker-Driven Therapeutic Management of Alzheimer’s Disease: Establishing the Foundations
Jeffrey L. Cummings, K. Zhong · 2013 · Clinical Pharmacology & Therapeutics
CSF metabolites associated with biomarkers of Alzheimer’s disease pathology
Ruocheng Dong, Qiongshi Lu, Hyunseung Kang, Ivonne Suridjan, Gwendlyn Kollmorgen, Norbert Wild, Yuetiva K. Deming, Carol Ann Van Hulle, Rozalyn M. Anderson, Henrik Zetterberg et al. · 2023 · Frontiers in Aging Neuroscience
Personalized health care beyond oncology: new indications for immunoassay‐based companion diagnostics
Richard Batrla, Bruce W.M. Jordan · 2015 · Annals of the New York Academy of Sciences
Plasma biomarkers are associated with agitation and regional brain atrophy in Alzheimer’s disease
Hsu, Jung-Lung, Lee, Wei-Ju, Liao, Yi-Chu, Lirng, Jiing-Feng, Wang, Shuu-Jiun, Fuh, Jong-Ling · 2017 · Scientific Reports
Alzheimer’s Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus
Salvatore Mazzeo, Filippo Emiliani, Silvia Bagnoli, Sonia Padiglioni, Lorenzo Maria Del Re, Giulia Giacomucci, Juri Balestrini, Assunta Ingannato, Valentina Moschini, Carmen Morinelli et al. · 2022 · Journal of Personalized Medicine
COVID-19 and Alzheimer's Disease: Neuroinflammation, Oxidative Stress, Ferroptosis, and Mechanisms Involved
Alicia Beatriz Pomilio, Arturo Alberto Vitale, Alberto Lazarowski · 2022 · Current Medicinal Chemistry
Phage‐Derived and Aberrant HaloTag Peptides Immobilized on Magnetic Microbeads for Amperometric Biosensing of Serum Autoantibodies and Alzheimer's Disease Diagnosis
Alejandro Valverde, Ana Montero‐Calle, Beatriz Arévalo, Pablo San Segundo‐Acosta, Verónica Serafín, Miren Alonso‐Navarro, Guillermo Solís‐Fernández, José Manuel Pingarrón, Susana Campuzano, Rodrigo Barderas · 2021 · Analysis & Sensing
Polyphenol Ellagic Acid-Targeting To Brain: A Hidden Treasure
Sidharth Mehan, Ramandeep Kaur, Shaba Parveen, Deepa Khanna, Sanjeev Kalra · 2015 · International Journal of Neurology Research
Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species
Francisco P. M. Oliveira, Antoine Leuzy, João Castelhano, Konstantinos Chiotis, Steen Gregers Hasselbalch, Juha O. Rinne, Alexandre de Mendonça, Markus Otto, Alberto Lleó, Isabel J. Santana et al. · 2018 · NeuroImage Clinical
Gradual Variation-Based Dual-Stream Deep Learning for Spatial Feature Enhancement With Dimensionality Reduction in Early Alzheimer’s Disease Detection
Najmul Hassan, Abu Saleh Musa Miah, Taro Suzuki, Jungpil Shin · 2025 · IEEE Access
Accelerated Alzheimer’s Aβ-42 secondary nucleation chronologically visualized on fibril surfaces
Peter Niraj Nirmalraj, Shayon Bhattacharya, Damien Thompson · 2024 · Science Advances
Evolving Relevance of Neuroproteomics in Alzheimer’s Disease
Simone Lista, Henrik Zetterberg, Sid E. O’Bryant, Kaj Blennow, Harald Juergen Hampel · 2017 · Methods in molecular biology
Nucleic acid liquid biopsies in Alzheimer's disease: current state, challenges, and opportunities
Tabea M. Soelter, Jordan H. Whitlock, Avery S. Williams, Andrew A. Hardigan, Brittany N. Lasseigne · 2022 · Heliyon
Challenges in the Neuropathological Diagnosis of Dementias
K. A. Jellinger · 2012 · International Journal of Neuropathology
Exploring the Potential of Neuroproteomics in Alzheimer's Disease
Md. Sahab Uddin, Md. Tanvir Kabir, Md. Jakaria, Eduardo Sobarzo‐Sánchez, George Emilio Barreto, Asma Perveen, Abdul Hafeez, May Nasser Bin-Jumah, Mohamed M. Abdel‐Daim, Ghulam Md Ashraf · 2020 · Current Topics in Medicinal Chemistry
The Biochemical Biomarkers Determination in Alzheimer Dementia
Victoria Bîrluțiu, Laura Ștef, Sebastian Ioan Cernusca Mitariu, Corina Roman-Filip, Lavinia Corina DUICA, Elisabeta Antonescu, Mihail Cristian Pîrlog, Traian Purnichi, Sînziana Călina Silişteanu, Marinela Minodora Manea · 2018 · Revista de Chimie
Predictive Accuracy of Blood-Derived Biomarkers for Amyloid-β Brain Deposition Along with the Alzheimer’s Disease Continuum: A Systematic Review
Alessandra Cianflone, Luigi Coppola, Peppino Mirabelli, Marco Salvatore · 2021 · Journal of Alzheimer s Disease
Gaussian Process-based prediction of memory performance and biomarker status in ageing and Alzheimer’s disease—A systematic model evaluation
Aditya Nemali, Niklas Vockert, David Berron, Anne Maaß, José Bernal, Renat Yakupov, Oliver Peters, Daria Gref, Nicoleta Carmen Cosma, Lukas Preis et al. · 2023 · Medical Image Analysis
MS4A6A/Ms4a6d deficiency disrupts neuroprotective microglia functions and promotes inflammation in Alzheimer’s disease model
Haishan Jiao, Yi‐Jun Ge, Liang-Yu Huang, Ying Liu, Bang‐Sheng Wu, Piaopiao Lian, Yizhe Hao, Shanshan Han, Yiting Li, Kaimin Wu et al. · 2025 · Molecular Neurodegeneration
Impact of frequent cerebrospinal fluid sampling on Aβ levels: systematic approach to elucidate influencing factors
Bianca Van Broeck, Maarten Timmers, Steven Ramael, Jennifer Bogert, Leslie M. J. Shaw, Marc H. Mercken, John Slemmon, Luc Van Nueten, Sebastiaan Engelborghs, Johannes Rolf Streffer · 2016 · Alzheimer s Research & Therapy
Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia‐specific perspectives
Takeshi Iwatsubo, Reisa Anne Sperling, Alicia Algeciras‐Schimnich, Hidenori Arai, Anna M. Barron, Tammie L.S. Benzinger, Marı́a C. Carrillo, Christopher Chen, Seong Hye Choi, Igor Camargo Fontana et al. · 2025 · Alzheimer s & Dementia
A lzheimer's Disease Biomarkers: More Than Molecular Diagnostics
Dave C. Anderson · 2013 · Drug Development Research
An analysis of factors predicting memory loss in Alzheimer's disease prevention
Mingzhao Hu, Yifei Zhang, N. Maritza Dowling · 2017 · International Joint Conference on Neural Networks (IJCNN)
Precision Medicine: Role of Biomarkers in Early Prediction and Diagnosis of Alzheimer’s Disease
Liming Shen, Sijian Xia, Huajie Zhang, Fang Yao, Xukun Liu, Yuxi Zhao, Ming Ying, Javed Iqbal, Qiong Liu · 2019 · IntechOpen eBooks
PSEN1 c.1292C<A Variant and Early-Onset Alzheimer’s Disease: A Scoping Review
Maribel Orozco-Barajas, Yulisa Oropeza-Ruvalcaba, Alejandro Arturo Canales-Aguirre, Víctor Javier Sánchez-González · 2022 · Frontiers in Aging Neuroscience
Advances in blood-based protein biomarkers for Alzheimer's disease
Lorraine F. Clark, Thomas J. Kodadek · 2013 · Alzheimer s Research & Therapy
A New Sandwich Immunoassay for Detection of the α-Secretase Cleaved, Soluble Amyloid-β Protein Precursor in Cerebrospinal Fluid and Serum
Mara Taverna, Tobias Straub, Harald Juergen Hampel, Dan Rujescu, Stefan F. Lichtenthaler · 2013 · Journal of Alzheimer s Disease
A Critical Analysis of the FDA’s Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity
Sarfaraz K. Niazi · 2023 · Pharmaceuticals
Tau Protein as a Biological Fluid Biomarker in Neurodegenerative Dementias
Franc Llorens, Anna Villar‐Piqué, Niccolò Candelise, Isidró Ferrer, Inga Zerr · 2019 · IntechOpen eBooks
The Cerebrospinal Fluid Free-Glycans Hex1 and HexNAc1Hex1Neu5Ac1 as Potential Biomarkers of Alzheimer’s Disease
Lynn Krüger, Karina Biskup, Carola G. Schipke, Bianca Kochnowsky, Luisa‐Sophie Schneider, Oliver Peters, Véronique Blanchard · 2024 · Biomolecules
Neuroproteomics Chip-Based Mass Spectrometry and Other Techniques for Alzheimer’s Disease Biomarkers – Update
Alicia Beatriz Pomilio, Arturo Alberto Vitale, Alberto Lazarowski · 2022 · Current Pharmaceutical Design
Aβ42 Expressing Drosophila melanogaster Model for Alzheimer's Disease: Quantitative Proteomics Identifies Altered Protein Dynamics of Relevance to Neurodegeneration
Sayali Chandrashekhar Deolankar, Mohammad Altaf Najar, Shamprasad Varija Raghu, Thottethodi Subrahmanya Keshava Prasad · 2022 · OMICS A Journal of Integrative Biology
Novel autoimmune response in a tauopathy mouse model
Carlos J. Nogueras‐Ortiz, Hector De Jesús‐Cortés, Jaime Vaquer‐Alicea, Irving E. Vega · 2014 · Frontiers in Neuroscience
The Synergistic Roles of the Chronic Prenatal and Offspring Stress Exposures in Impairing Offspring Learning and Memory
Wei Xue Tang, Juan Cheng, Zheng‐Yu Wang, Keyang Chen, Zhenmin Han, Qihong Wang, Yuyou Yao · 2016 · Journal of Alzheimer s Disease
Bias-generating factors in biofluid amyloid-β measurements for Alzheimer’s disease diagnosis
Sohui Park, Young Soo Kim · 2021 · Biomedical Engineering Letters
CSF-Targeted Proteomics Indicate Amyloid-Beta Ratios in Patients with Alzheimer’s Dementia Spectrum
Maryam Behzad, Negin Zirak, Ghazal Hamidi Madani, Linda Baidoo, Ali Rezaei, Shima Karbasi, Mohammad Reza Sadeghi, Mahan Shafie, Mahsa Mayeli, Alzheimer’s Disease Neuroimaging Initiative · 2023 · International Journal of Alzheimer s Disease
Event related potentials (ERPs) and alpha waves in cognition, aging and selected dementias: A source of biomarkers and therapy
Priya Mirand, Christopher D. Cox, Michael Alexander, Slav Danev, Jonathan R. T. Lakey · 2019 · Integrative Molecular Medicine
MRI-based Alzheimer’s disease classification using Vision Transformer and time-series transformer: A step-by-step guide
Sait Alp, Sara Akan, Taymaz Akan, Mohammad Alfrad Nobel Bhuiyan · 2025 · Software Impacts
Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration
Jamie Toombs, Martha S. Foiani, Ross W. Paterson, Amanda Heslegrave, Selina Wray, Jonathan M. Schott, Nick C. Fox, Michael Peter Lunn, Kaj Blennow, Henrik Zetterberg · 2017 · Journal of Alzheimer s Disease
Lipidomics and proteomics: An integrative approach for early diagnosis of dementia and Alzheimer’s disease
Virendra Tiwari, Shubha Shukla · 2023 · Frontiers in Genetics
Amyloid β42 and Total Tau Levels in Cerebrospinal Fluid Associate with Survival in an 85-Year-Old Population-Based Cohort Followed until Death
Mats Ribbe, Silke Kern, Anne Börjesson‐Hanson, Svante Östling, Henrik Zetterberg, Kaj Blennow, Ingmar Gr. Skoog · 2019 · Dementia and Geriatric Cognitive Disorders
Differential patterns of lysosomal dysfunction are seen in the clinicopathological forms of primary progressive aphasia
Imogen J. Swift, Simon Sjödin, Johan Gobom, Ann Brinkmalm, Kaj Blennow, Henrik Zetterberg, Jonathan Daniel Rohrer, Aitana Sogorb‐Esteve · 2023 · Journal of Neurology
Supportive CSF biomarker evidence to enhance the National Institute on Aging-Alzheimer's Association criteria for diagnosis of Alzheimer's type dementia – A study from Southern India
Chandrashekar B. Huded, Srikala Bharath, SadanandavalliR Chandra, Palanimuthu Thangaraju Sivakumar, Mathew Varghese, Sarada Subramanian · 2014 · Asian Journal of Psychiatry
Recent Advancements in the Early Diagnosis and Treatment of Alzheimer's Disease
Ye Wu, Li Fu, Qianqian Li, Xiang Gao, Yingjun Zhang, Chuanfei Jin, Feiqing Ding, Sheng Chiong Hong, Hui Cai, Yiliang Li · 2023 · Advanced Therapeutics
Alzheimer and It’s Possible Therapy: A Review
2020 · Journal of Experimental Neurology
Differential Impairment of Cerebrospinal Fluid Synaptic Biomarkers in the Genetic Forms of Frontotemporal Dementia
Aitana Sogorb‐Esteve, Johanna Nilsson, Imogen J. Swift, Carolin Heller, Lucy Louise Russell, Georgia Peakman, Rhian S. Convery, John Cornelis Van Swieten, Harro Seelaar, Barbara Borroni et al. · 2022 · Research Square
Separating dementia with Lewy bodies from Alzheimer’s disease dementia using a volumetric MRI classifier
Aniek M. van Gils, Antti J Tolonen, Hanneke F. M. Rhodius‐Meester, Patrizia Mecocci, Ritva L. Vanninen, Kristian Steen Frederiksen, Frederik Barkhof, Bas Jasperse, Jyrki M. P. Lötjönen, Wiesje M. van der Flier et al. · 2024 · European Radiology
Statistical estimation and comparison of group-specific bivariate correlation coefficients in family-type clustered studies
Jingqin Rosy Luo, Feng Gao, Jingxia Liu, Guoqiao Wang, Ling Chen, Anne M. Fagan, Gregory Scott Day, Jonathan Vöglein, Jasmeer P. Chhatwal, Chengjie Xiong et al. · 2021 · Journal of Applied Statistics
Dementia
Gunnar K. Gouras · 2014 · Elsevier eBooks
Brain white matter damage biomarkers
Fardin Nabizadeh · 2024 · Advances in clinical chemistry
Alzheimer´s Disease-associated Aβ42 Peptide: Expression and Purification for NMR Structural Studies
Montserrat Serra-Batiste, Raquel García-Castellanos, Martí Ninot‐Pedrosa, Bernat Serra-Vidal, Nicholas Simon Berrow, Natàlia Carulla · 2017 · Current Chemical Biology
Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer’s Disease
Mari Aksnes, Ann Tiiman, Trine Holt Edwin, Lars Y. Terenius, Nenad Bogdanović, Vladana B. Vukojević, Anne‐Brita Knapskog · 2021 · Frontiers in Aging Neuroscience
Attenuated task-responsive representations of hippocampal place cells induced by amyloid-beta accumulation
Yimeng Wang, Xueling Wang, Ling Wang, Zheng Li, Xingwei An, Chenguang Zheng · 2024 · Behavioural Brain Research
The Cerebrospinal Fluid in Severe Pain Conditions : Clinical, Pharmacological and Proteomic Aspects
Emmanuel Bäckryd · 2015 · Linköping University Electronic Press eBooks
The Pattern of Cortical Lesions in Preclinical Stages
Heiko Braak, Kelly Del Tredici · 2014 · Advances in anatomy, embryology and cell biology
An eye’s look unmasks the mystery: correlation between serum amyloid beta peptide, hippocampal volume and retinal thickness in Alzheimer`s disease
Ali Ahmed Abou Elmaaty, Mona Ali Eissa, Shady Khalil El-Rashedy, Hamada Ibrahim Zehry, Ahmed A.H. Mosa, Carmen Ali Zarad, Marwa A. Abdel-Dayem, Amgad El Nokrashy, Saad Shawki Elsherifi · 2024 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
Diagnosis of Alzheimer’s Disease, Types of Plaques and Their Detection, Imaging Techniques, and Other Tests
Tazeen Qureshi, Subashchandrabose Chinnathambi · 2024 · Springer eBooks
Cerebrospinal Fluid Biomarkers of Preclinical Alzheimer’s Disease
Panagiotis Alexopoulos, Chaido Sirinian · 2018 · Neuromethods
Shifting Paradigm in Early Detection and Prediction of Alzheimer's Disease
Tabassum Bashir, Deoshree Akhouri, Hamza Hamza · 2024 · Advances in medical technologies and clinical practice book series
Buchholzia coriacea seed attenuates scopolamine-induced memory impairment in Mice by down-regulating oxidative stress biomarkers
Lawrence Dayo Adedayo, Nimedia G. Aitokhuehi, Olubayode Bamidele, Adeshina Oloruntoba Adekeye, Abayomi Mayowa Ajayi, Samuel Adetunji Onasanwo · 2025 · Journal of Ethnopharmacology
Computational Risk Stratification of Preclinical Alzheimer’s in Younger Adults
Oriehi Edisemi Destiny Anyaiwe, Nandini Nataraj, Bhargava Sai Gudikandula · 2025 · Diagnostics
Alzheimer’s Disease: A Clinical Perspective
Weili Xu, Anna Marseglia, Camilla Ferrari, Hui‐Xin Wang · 2013 · InTech eBooks
Quantitative analysis of synaptic pathology and neuroinflammation: an initial study in a female rhesus monkey model of the “synaptic” phase of Alzheimer’s disease
Danielle Beckman, Kristine Donis‐Cox, Sean P. Ott, Mary Ann Roberts, Lisa Novik, William G.M. Janssen, Eliza Bliss‐Moreau, Peter H. Rudebeck, Mark G. Baxter, John H. Morrison · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
Individualized Gaussian Process-based Prediction of Memory Performance and Biomarker Status in Ageing and Alzheimer’s disease
Aditya Nemali, Niklas Vockert, David Berron, Anne Maaß, Renat Yakupov, Oliver Peters, Daria Gref, Nicoleta Carmen Cosma, Lukas Preis, Josef Priller et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Biomarkers as Monitors of Drug Effect, Diagnostic Tools and Predictors of Deterioration Rate in Alzheimer’s Disease
Malin Degerman Gunnarsson · 2013
Influence of genetic variability and external regulating factors on amyloid-beta peptide aggregation
Ellen Hubin · 2014
Etiological and clinical studies of Langerhans Cell Histiocytosis (LCH)
Selma Olsson Åkefeldt · 2013 · Figshare
New Frontiers in Alzheimer's Disease Diagnosis
Franc Llorens, Sabine Nuhn, Christoph Peter, Inga Zerr, Katharina Stoeck · 2015 · InTech eBooks
Aβ-mediated changes in CREB and ERK activity in cultured cortical neurons : involvement of NMDA receptors
Valéria de Rosa · 2013
Mass spectrometric quantification of amyloid-beta in cerebrospinal fluid and plasma Implications for Alzheimer's disease
Josef Pannee · 2015
Neuroimaging and laboratory aspects
Leonardo Pantoni, Philip B. Gorelick · 2014 · Cambridge University Press eBooks
Neurologische und dementielle Erkrankungen
Wolf‐Dieter Heiss, Lutz Kracht · 2016 · Springer eBooks
Cerebral small vessel disease: cerebrospinal fluid aspects
Anders Wallin, Maria Bjerke · 2014 · Cambridge University Press eBooks
Amyloidassoziierte Krankheiten des Zentralnervensystems: multimodale Befundung
Michelle M. Miller‐Thomas, Adam L. Sipe, Tammie L.S. Benzinger, Jonathan McConathy, Sarah Connolly, Katherine E. Schwetye · 2017 · Neuroradiologie Scan
Amyloid beta: from pre-analytical factors to disease mechanisms
Jamie Toombs · 2019 · UCL Discovery (University College London)
Understanding and improving the diagnosis of dementia with Lewy bodies
Joseph P. M. Kane · 2019
Współczesna diagnostyka laboratoryjna choroby Alzheimera
Brygida Beck, Bożena Siudek · 2019
Neurofilament Light Chain als Prädiktor kognitiven Abbaus bei Mild Cognitive Impairment
Miriam Berens · 2021
Differential Impairment Of Cerebrospinal Fluid Synaptic Biomarkers In The Genetic Forms Of Frontotemporal Dementia
Aitana Sogorb‐Esteve, Johanna Nilsson, Imogen J. Swift, Carolin Heller, Lucy Louise Russell, Georgia Peakman, Rhian S. Convery, John Cornelis Van Swieten, Harro Seelaar, Barbara Borroni et al. · 2022 · Research Square
Quantifying soluble isoforms of amyloid precursor protein in cerebrospinal fluid with a SRM-MS based assay ─ method development
Elin Lindström · 2013 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Proximity extension assay-based proteomic studies in Alzheimer’s disease
Emiş Cansu Yaka, Şermin Genç · 2024 · Turkish Journal Of Neurology
Digital tools to support dementia diagnosis
Aniek M. van Gils · 2024
Interventional Neuroimaging: Techniques, Applications, and Future Directions
Sadia Sana, Maryam Afzaal, Yasmin Mushtaq, Mamoona Tariq, Naheed Akhter · 2025 · IntechOpen eBooks
Detection of the Alzheimer's disease soluble amyloid precursor protein and modulation of its proteolytic processing
Taverna, Mara · 2014 · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)
Single Molecule Detection using Optical Waveguide
Mathias Elmeskog · 2013